Catalyst Wire Dossier Catalyst Wire Dossier

Tazarotene 0.1% Cream

tazarotene
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tazarotene 0.1% Cream, covering 2008-10-24 to 2008-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study [Phase 1, Phase 2]

See pricing